Dermapharm Holding SE (DMP.DE)

EUR 39.2

(1.82%)

Inventory Summary of Dermapharm Holding SE

Dermapharm Holding SE's latest annual inventory in 2023 was 320.75 Million EUR , up 27.37% from previous year.
Dermapharm Holding SE's latest quarterly inventory in 2024 Q2 was 350.71 Million EUR , up 3.92% from previous quarter.
Dermapharm Holding SE reported annual inventory of 251.82 Million EUR in 2022, up 4.69% from previous year.
Dermapharm Holding SE reported annual inventory of 240.53 Million EUR in 2021, up 18.34% from previous year.
Dermapharm Holding SE reported quarterly inventory of 350.71 Million EUR for 2024 Q2, up 3.92% from previous quarter.
Dermapharm Holding SE reported quarterly inventory of 326.92 Million EUR for 2023 Q2, up 3.66% from previous quarter.

Annual Inventory Chart of Dermapharm Holding SE (2023 - 2013)

Historical Annual Inventory of Dermapharm Holding SE (2023 - 2013)

Year	Inventory	Inventory Growth
2023	320.75 Million EUR	27.37%
2022	251.82 Million EUR	4.69%
2021	240.53 Million EUR	18.34%
2020	203.26 Million EUR	18.06%
2019	172.16 Million EUR	48.98%
2018	115.56 Million EUR	42.48%
2017	81.1 Million EUR	-4.11%
2016	84.58 Million EUR	9.97%
2015	76.91 Million EUR	8.1%
2014	71.14 Million EUR	5.38%
2013	67.51 Million EUR	0.0%

Year	Inventory	Inventory Growth
2024 Q1	337.48 Million EUR	5.21%
2024 Q2	350.71 Million EUR	3.92%
2023 Q2	326.92 Million EUR	3.66%
2023 Q3	333.18 Million EUR	1.91%
2023 FY	320.75 Million EUR	27.37%
2023 Q1	315.36 Million EUR	25.23%
2023 Q4	320.75 Million EUR	-3.73%
2022 Q2	272.84 Million EUR	1.73%
2022 Q4	251.82 Million EUR	-8.49%
2022 FY	251.82 Million EUR	4.69%
2022 Q1	268.21 Million EUR	11.51%
2022 Q3	275.17 Million EUR	0.85%
2021 Q1	216.1 Million EUR	6.32%
2021 FY	240.53 Million EUR	18.34%
2021 Q4	240.53 Million EUR	0.86%
2021 Q3	238.48 Million EUR	3.17%
2021 Q2	231.15 Million EUR	6.96%
2020 Q2	213.34 Million EUR	14.7%
2020 Q4	203.26 Million EUR	-9.94%
2020 Q1	185.99 Million EUR	8.03%
2020 Q3	225.69 Million EUR	5.79%
2020 FY	203.26 Million EUR	18.06%
2019 Q3	177.18 Million EUR	15.99%
2019 FY	172.16 Million EUR	48.98%
2019 Q1	162.2 Million EUR	40.36%
2019 Q2	152.76 Million EUR	-5.82%
2019 Q4	172.16 Million EUR	-2.83%
2018 Q2	113.29 Million EUR	9.62%
2018 FY	115.56 Million EUR	42.48%
2018 Q4	115.56 Million EUR	6.92%
2018 Q3	108.07 Million EUR	-4.61%
2018 Q1	103.34 Million EUR	27.42%
2017 Q4	81.1 Million EUR	-1.02%
2017 Q3	81.93 Million EUR	0.0%
2017 Q1	- EUR	-100.0%
2017 FY	81.1 Million EUR	-4.11%
2016 FY	84.58 Million EUR	9.97%
2016 Q4	84.58 Million EUR	0.0%
2015 FY	76.91 Million EUR	8.1%
2014 FY	71.14 Million EUR	5.38%
2013 FY	67.51 Million EUR	0.0%

Peer Inventory Comparison of Dermapharm Holding SE

Name	Inventory	Inventory Difference
MPH Health Care AG	- EUR	-Infinity%
Apontis Pharma AG	6.6 Million EUR	-4759.97%
Evotec SE	30.89 Million EUR	-938.388%
MERCK Kommanditgesellschaft auf Aktien	4.63 Billion EUR	93.083%
PharmaSGP Holding SE	10.11 Million EUR	-3070.485%
SynBiotic SE	2.76 Million EUR	-11502.342%